Gritstone bio, Inc.
GRTSNASDAQHealthcare
$0.03
$-0.02(-31.78%)
Market Cap$3803110
P/E Ratio—
52W High$3.17
52W Low$0.03
Gritstone bio, Inc. (GRTS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GRTS · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2024Report Date: Nov 13, 2024EPS Actual
-$0.33
Est. -$0.19 · -73.7%
Revenue
—
Fiscal Period
Q4 FY2024
FY ends December
Report Date
Nov 13, 2024
After Market Close
▼ Miss EPS
GRTS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2025 | Aug 11, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 7, 2025 | — | — | — | — | — | — |
| ◌ Q1 FY2025 | Mar 3, 2025 | — | — | — | — | — | — |
| ▼ Q4 FY2024 | Nov 13, 2024 | -$0.19 | -$0.33 | -73.7% | — | — | — |
| ▲ Q3 FY2024 | Aug 13, 2024 | -$0.26 | -$0.16 | +38.5% | $0.00B | $0.00B | -95.8% |
| ▼ Q2 FY2024 | May 9, 2024 | -$0.30 | -$0.34 | -13.3% | $0.00B | $0.00B | -95.5% |
| ▲ Q1 FY2024 | Mar 5, 2024 | -$0.36 | -$0.26 | +27.8% | $0.00B | $0.00B | -99.3% |
| ▲ Q4 FY2023 | Nov 8, 2023 | -$0.35 | -$0.33 | +5.7% | $0.00B | $0.00B | -61.6% |
Q3 FY2025
Aug 11, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 7, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Mar 3, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 13, 2024Miss
EPS Actual
-$0.33
EPS Est.
-$0.19
EPS Surpr.
-73.7%
Revenue
—
Q3 FY2024
Aug 13, 2024Beat
EPS Actual
-$0.16
EPS Est.
-$0.26
EPS Surpr.
+38.5%
Revenue
$0.00B
Q2 FY2024
May 9, 2024Miss
EPS Actual
-$0.34
EPS Est.
-$0.30
EPS Surpr.
-13.3%
Revenue
$0.00B
Q1 FY2024
Mar 5, 2024Beat
EPS Actual
-$0.26
EPS Est.
-$0.36
EPS Surpr.
+27.8%
Revenue
$0.00B
Q4 FY2023
Nov 8, 2023Beat
EPS Actual
-$0.33
EPS Est.
-$0.35
EPS Surpr.
+5.7%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $-0.21 | $-0.21 | $-0.21 | 1 |
| Q3 FY2025 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Q2 FY2025 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q1 FY2025 | $-0.18 | $-0.18 | $-0.18 | 1 |
| Q4 FY2024 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Q3 FY2024 | $-0.17 | $-0.17 | $-0.17 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2024 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2024 | Nov 13, 2024 | -73.7% | $0.03 | $0.03 | -10.00% |
| ▲ Q3 FY2024 | Aug 13, 2024 | +38.5% | $0.49 | $0.52 | +5.57% |
| ▼ Q2 FY2024 | May 9, 2024 | -13.3% | $0.98 | $0.97 | -1.11% |
| ▲ Q1 FY2024 | Mar 5, 2024 | +27.8% | $2.13 | $2.04 | -4.23% |
| ▲ Q4 FY2023 | Nov 8, 2023 | +5.7% | $1.83 | $1.69 | -7.65% |
| ▲ Q3 FY2023 | Aug 9, 2023 | +8.8% | $1.75 | $1.75 | +0.00% |
| ▲ Q2 FY2023 | May 11, 2023 | +6.3% | $2.65 | $2.61 | -1.51% |
| ▲ Q1 FY2023 | Mar 9, 2023 | +3.2% | $2.38 | $2.31 | -2.94% |
Q4 FY2024-10.00%
Report Date
Nov 13, 2024
EPS Beat/Miss
-73.7%
Price Before
$0.03
Price After
$0.03
Q3 FY2024+5.57%
Report Date
Aug 13, 2024
EPS Beat/Miss
+38.5%
Price Before
$0.49
Price After
$0.52
Q2 FY2024-1.11%
Report Date
May 9, 2024
EPS Beat/Miss
-13.3%
Price Before
$0.98
Price After
$0.97
Q1 FY2024-4.23%
Report Date
Mar 5, 2024
EPS Beat/Miss
+27.8%
Price Before
$2.13
Price After
$2.04
Q4 FY2023-7.65%
Report Date
Nov 8, 2023
EPS Beat/Miss
+5.7%
Price Before
$1.83
Price After
$1.69
Q3 FY2023+0.00%
Report Date
Aug 9, 2023
EPS Beat/Miss
+8.8%
Price Before
$1.75
Price After
$1.75
Q2 FY2023-1.51%
Report Date
May 11, 2023
EPS Beat/Miss
+6.3%
Price Before
$2.65
Price After
$2.61
Q1 FY2023-2.94%
Report Date
Mar 9, 2023
EPS Beat/Miss
+3.2%
Price Before
$2.38
Price After
$2.31
Avg Beat Reaction-1.79%
Avg Miss Reaction-5.55%
Beat Rate6 / 8 quarters
Largest Move-10.00% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GRTS ends December
Gritstone bio, Inc. (GRTS) most recently reported earnings on November 13, 2024 for Q4 FY2024, posting EPS of $-0.33 — missing the analyst consensus of $-0.19 by -73.7%. The next GRTS earnings date is expected around September 1, 2026.
Each quarter, investors track GRTS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GRTS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GRTS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GRTS earnings · 5 questionsGritstone bio, Inc.'s next earnings report is expected around September 1, 2026. GRTS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GRTS historically reports after market close (AMC).
GRTS earnings datewhen is GRTS earningsGRTS next earnings datewhen does GRTS report earningsGRTS earnings calendar
▸ Source: FMP · Gritstone bio, Inc. SEC filings · US GAAP · Gritstone bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026